Pancreatic duct replication is increased with obesity and type 2 diabetes in humans

被引:84
作者
Butler, A. E. [1 ]
Galasso, R. [1 ]
Matveyenko, A. [1 ]
Rizza, R. A. [2 ]
Dry, S. [3 ]
Butler, P. C. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Larry Hillblom Islet Res Ctr, Los Angeles, CA 90024 USA
[2] Mayo Med Coll, Endocrine Res Unit, Rochester, MN USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90024 USA
关键词
DPP-IVinhibitor; GLP-1; Obesity; Pancreatic cancer; Pancreatic ductal; Pancreatitis; BETA-CELL DEFICIT; TUBULAR COMPLEXES; HIP RAT; CANCER; MODEL; MASS; APOPTOSIS;
D O I
10.1007/s00125-009-1556-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a high-fat-fed rat model of type 2 diabetes we noted increased exocrine duct replication. This is a predisposing factor for pancreatitis and pancreatic cancer, both of which are more common in type 2 diabetes. The aim of the study reported here was to establish if obesity and/or type 2 diabetes are associated with increased pancreatic ductal replication in humans. We obtained pancreas at autopsy from 45 humans, divided into four groups: lean (BMI < 25 kg/m(2)); obese (BMI > 27 kg/m(2)); non-diabetic; and with type 2 diabetes. Pancreases were evaluated after immunostaining for the duct cell marker cytokeratin and Ki67 for replication. We show for the first time that both obesity and type 2 diabetes in humans are associated with increased pancreatic ductal replication. Specifically, we report that (1) replication of pancreatic duct cells is increased tenfold by obesity, and (2) lean subjects with type 2 diabetes demonstrate a fourfold increase in replication of pancreatic duct cells compared with their lean non-diabetic controls. Pancreatic duct cell replication is increased in humans in response to both obesity and type 2 diabetes, potentially providing a mechanism for the increased risk of pancreatitis and pancreatic cancer in those with obesity and/or type 2 diabetes.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 14 条
[1]   ORIGIN OF TUBULAR COMPLEXES IN HUMAN CHRONIC-PANCREATITIS [J].
BOCKMAN, DE ;
BOYDSTON, WR ;
ANDERSON, MC .
AMERICAN JOURNAL OF SURGERY, 1982, 144 (02) :243-249
[2]   β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes [J].
Butler, AE ;
Janson, J ;
Bonner-Weir, S ;
Ritzel, R ;
Rizza, RA ;
Butler, PC .
DIABETES, 2003, 52 (01) :102-110
[3]   Diabetes due to a progressive defect in β-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat) -: A new model for type 2 diabetes [J].
Butler, AE ;
Jang, J ;
Gurlo, T ;
Carty, MD ;
Soeller, WC ;
Butler, PC .
DIABETES, 2004, 53 (06) :1509-1516
[4]   Contribution of obesity to pancreatic carcinogenesis [J].
Gumbs, Andrew A. ;
Bessler, Marc ;
Milone, Luca ;
Schrope, Beth ;
Chabot, John .
SURGERY FOR OBESITY AND RELATED DISEASES, 2008, 4 (02) :186-193
[5]   Obesity, pancreatitis, and pancreatic cancer [J].
Gumbs, Andrew A. .
OBESITY SURGERY, 2008, 18 (09) :1183-1187
[6]   β-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes [J].
Matveyenko, Aleksey V. ;
Butler, Peter C. .
DIABETES, 2006, 55 (07) :2106-2114
[7]   Beneficial Endocrine but Adverse Exocrine Effects of Sitagliptin in the Human Islet Amyloid Polypeptide Transgenic Rat Model of Type 2 Diabetes Interactions With Metformin [J].
Matveyenko, Aleksey V. ;
Dry, Sarah ;
Cox, Heather I. ;
Moshtaghian, Artemis ;
Gurlo, Tatyana ;
Galasso, Ryan ;
Butler, Alexandra E. ;
Butler, Peter C. .
DIABETES, 2009, 58 (07) :1604-1615
[8]   Incretins and the development of type 2 diabetes [J].
Meier J.J. ;
Nauck M.A. .
Current Diabetes Reports, 2006, 6 (3) :194-201
[9]  
PARSA I, 1985, CANCER RES, V45, P1285
[10]   Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies [J].
Renehan, Andrew G. ;
Tyson, Margaret ;
Egger, Matthias ;
Heller, Richard F. ;
Zwahlen, Marcel .
LANCET, 2008, 371 (9612) :569-578